24 participants
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-12-28
- Start Date:
- 2007-06-30
- Completion:
- 2011-07-31
Conditions
- Melanoma
- Skin Cancer
Interventions
- BIOLOGICAL
- DRUG